Daxor Corporation (DXR)
USD 8.2
(-0.97%)
USD 8.2
(-0.97%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.1 Million USD | 558.85% |
| 2022 | 5.22 Million USD | 8.37% |
| 2021 | 4.81 Million USD | 386.42% |
| 2020 | -1.68 Million USD | -249.0% |
| 2019 | -482.15 Thousand USD | 59.38% |
| 2018 | -1.18 Million USD | 2.04% |
| 2017 | -1.21 Million USD | -177.74% |
| 2016 | 1.55 Million USD | 120.09% |
| 2015 | -7.75 Million USD | -91.4% |
| 2014 | -4.05 Million USD | 64.93% |
| 2013 | -11.55 Million USD | -449.78% |
| 2012 | -2.1 Million USD | -436.4% |
| 2011 | 624.91 Thousand USD | -26.62% |
| 2010 | 851.6 Thousand USD | -13.45% |
| 2009 | 983.96 Thousand USD | -20.97% |
| 2008 | 1.24 Million USD | -10.69% |
| 2007 | 1.39 Million USD | 51.4% |
| 2006 | 920.7 Thousand USD | 4089.98% |
| 2005 | 21.97 Thousand USD | -98.2% |
| 2004 | 1.21 Million USD | -61.51% |
| 2003 | 3.16 Million USD | 17.15% |
| 2002 | 2.7 Million USD | 256.28% |
| 2001 | 758.36 Thousand USD | 1.69% |
| 2000 | 745.78 Thousand USD | 29.62% |
| 1999 | 575.37 Thousand USD | 91.79% |
| 1998 | 300 Thousand USD | -40.0% |
| 1997 | 500 Thousand USD | -82.14% |
| 1996 | 2.8 Million USD | -40.43% |
| 1995 | 4.7 Million USD | 2.17% |
| 1994 | 4.6 Million USD | -4.17% |
| 1993 | 4.8 Million USD | -21.31% |
| 1992 | 6.1 Million USD | 56.41% |
| 1991 | 3.9 Million USD | -15.22% |
| 1990 | 4.6 Million USD | 109.09% |
| 1989 | 2.2 Million USD | -50.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -54.36 Thousand USD | 0.0% |
| 2024 Q1 | 35.87 Thousand USD | -99.9% |
| 2023 Q3 | 41.22 Thousand USD | 101.87% |
| 2023 Q1 | 40.48 Thousand USD | 103.85% |
| 2023 FY | 34.41 Million USD | 558.85% |
| 2023 Q4 | 36.35 Million USD | 88089.97% |
| 2023 Q2 | -2.19 Million USD | -5533.48% |
| 2022 Q4 | -1.05 Million USD | -2279.14% |
| 2022 Q3 | 48.19 Thousand USD | 112.36% |
| 2022 Q1 | 67.62 Thousand USD | 103.73% |
| 2022 FY | 5.22 Million USD | 8.37% |
| 2022 Q2 | -390.1 Thousand USD | -676.89% |
| 2021 Q3 | 76.21 Thousand USD | 104.23% |
| 2021 Q2 | -1.8 Million USD | -2969.27% |
| 2021 FY | 4.81 Million USD | 386.42% |
| 2021 Q4 | -1.81 Million USD | -2480.05% |
| 2021 Q1 | 62.82 Thousand USD | 103.34% |
| 2020 Q1 | 59.47 Thousand USD | -96.64% |
| 2020 Q2 | -1.61 Million USD | -2814.61% |
| 2020 FY | -1.68 Million USD | -249.0% |
| 2020 Q3 | 72.74 Thousand USD | 104.51% |
| 2020 Q4 | -1.87 Million USD | -2681.95% |
| 2019 Q3 | 93.6 Thousand USD | 123.43% |
| 2019 FY | -482.15 Thousand USD | 59.38% |
| 2019 Q1 | 96.46 Thousand USD | 207.68% |
| 2019 Q2 | -399.45 Thousand USD | -514.1% |
| 2019 Q4 | 1.76 Million USD | 1789.38% |
| 2018 Q1 | 114.76 Thousand USD | 322.91% |
| 2018 Q3 | 100.21 Thousand USD | 338.34% |
| 2018 Q4 | -89.58 Thousand USD | -189.39% |
| 2018 FY | -1.18 Million USD | 2.04% |
| 2018 Q2 | -42.04 Thousand USD | -136.64% |
| 2017 Q3 | 137.65 Thousand USD | 152.1% |
| 2017 Q4 | 27.13 Thousand USD | -80.29% |
| 2017 FY | -1.21 Million USD | -177.74% |
| 2017 Q1 | 138.05 Thousand USD | 507.42% |
| 2017 Q2 | 54.6 Thousand USD | -60.45% |
| 2016 Q2 | 136.73 Thousand USD | 0.0% |
| 2016 FY | 1.55 Million USD | 120.09% |
| 2016 Q4 | 22.72 Thousand USD | -82.53% |
| 2016 Q3 | 130.07 Thousand USD | -4.87% |
| 2016 Q1 | 136.73 Thousand USD | -30.72% |
| 2015 FY | -7.75 Million USD | -91.4% |
| 2015 Q3 | 197.35 Thousand USD | -39.58% |
| 2015 Q4 | 197.35 Thousand USD | 0.0% |
| 2015 Q2 | 326.63 Thousand USD | 0.0% |
| 2015 Q1 | 326.63 Thousand USD | -21.92% |
| 2014 Q2 | 387.96 Thousand USD | 0.0% |
| 2014 FY | -4.05 Million USD | 64.93% |
| 2014 Q1 | 387.96 Thousand USD | -26.23% |
| 2014 Q4 | 418.31 Thousand USD | 0.0% |
| 2014 Q3 | 418.31 Thousand USD | 7.82% |
| 2013 Q4 | 525.9 Thousand USD | 0.0% |
| 2013 Q1 | 497.86 Thousand USD | -16.77% |
| 2013 FY | -11.55 Million USD | -449.78% |
| 2013 Q3 | 525.9 Thousand USD | 5.63% |
| 2013 Q2 | 497.86 Thousand USD | 0.0% |
| 2012 FY | -2.1 Million USD | -436.4% |
| 2012 Q4 | 598.16 Thousand USD | 0.0% |
| 2012 Q3 | 598.16 Thousand USD | 0.0% |
| 2011 Q1 | 377.46 Thousand USD | -55.68% |
| 2011 Q3 | 311.13 Thousand USD | 12.37% |
| 2011 Q4 | 655.55 Thousand USD | 110.7% |
| 2011 FY | 624.91 Thousand USD | -26.62% |
| 2011 Q2 | 276.87 Thousand USD | -26.65% |
| 2010 FY | 851.6 Thousand USD | -13.45% |
| 2010 Q4 | 851.6 Thousand USD | 87.88% |
| 2010 Q3 | 453.28 Thousand USD | 23.06% |
| 2010 Q2 | 368.33 Thousand USD | -7.05% |
| 2010 Q1 | 396.27 Thousand USD | -59.73% |
| 2009 Q4 | 983.96 Thousand USD | 137.46% |
| 2009 FY | 983.96 Thousand USD | -20.97% |
| 2009 Q1 | 401.41 Thousand USD | 318.45% |
| 2009 Q2 | 380.42 Thousand USD | -5.23% |
| 2009 Q3 | 414.37 Thousand USD | 8.93% |
| 2008 Q1 | 300.74 Thousand USD | 4536.42% |
| 2008 Q3 | 330.77 Thousand USD | -24.22% |
| 2008 Q4 | -183.75 Thousand USD | -155.55% |
| 2008 FY | 1.24 Million USD | -10.69% |
| 2008 Q2 | 436.48 Thousand USD | 45.14% |
| 2007 Q2 | 545.31 Thousand USD | 7.8% |
| 2007 FY | 1.39 Million USD | 51.4% |
| 2007 Q3 | 193.31 Thousand USD | -64.55% |
| 2007 Q1 | 505.88 Thousand USD | -45.06% |
| 2007 Q4 | -6779.00 USD | -103.51% |
| 2006 Q1 | 342.14 Thousand USD | 948.11% |
| 2006 Q4 | 920.7 Thousand USD | 119.14% |
| 2006 Q3 | 420.14 Thousand USD | 7.92% |
| 2006 Q2 | 389.32 Thousand USD | 13.79% |
| 2006 FY | 920.7 Thousand USD | 4089.98% |
| 2005 Q1 | 296.58 Thousand USD | 115.09% |
| 2005 Q2 | 270.65 Thousand USD | -8.74% |
| 2005 Q3 | 340.79 Thousand USD | 25.91% |
| 2005 Q4 | 32.64 Thousand USD | -90.42% |
| 2005 FY | 21.97 Thousand USD | -98.2% |
| 2004 Q2 | 933.23 Thousand USD | -17.45% |
| 2004 Q3 | 1.11 Million USD | 19.96% |
| 2004 Q4 | -1.96 Million USD | -275.51% |
| 2004 FY | 1.21 Million USD | -61.51% |
| 2004 Q1 | 1.13 Million USD | 50.34% |
| 2003 Q4 | 751.97 Thousand USD | -16.83% |
| 2003 FY | 3.16 Million USD | 17.15% |
| 2003 Q3 | 904.18 Thousand USD | 17.17% |
| 2003 Q1 | 737.61 Thousand USD | 49.7% |
| 2003 Q2 | 771.66 Thousand USD | 4.62% |
| 2002 Q1 | 661.83 Thousand USD | 152.8% |
| 2002 Q4 | 492.74 Thousand USD | -37.96% |
| 2002 Q2 | 753.08 Thousand USD | 13.79% |
| 2002 FY | 2.7 Million USD | 256.28% |
| 2002 Q3 | 794.27 Thousand USD | 5.47% |
| 2001 Q2 | 679.58 Thousand USD | 4.94% |
| 2001 Q1 | 647.62 Thousand USD | 328.66% |
| 2001 FY | 758.36 Thousand USD | 1.69% |
| 2001 Q4 | -1.25 Million USD | -283.09% |
| 2001 Q3 | 684.59 Thousand USD | 0.74% |
| 2000 FY | 745.78 Thousand USD | 29.62% |
| 2000 Q2 | 150.43 Thousand USD | -36.26% |
| 2000 Q1 | 236 Thousand USD | 213.1% |
| 2000 Q3 | 182.47 Thousand USD | 21.3% |
| 2000 Q4 | 151.08 Thousand USD | -17.21% |
| 1999 Q1 | 100 Thousand USD | 0.0% |
| 1999 FY | 575.37 Thousand USD | 91.79% |
| 1999 Q4 | 75.37 Thousand USD | -62.31% |
| 1999 Q3 | 200 Thousand USD | 100.0% |
| 1999 Q2 | 100 Thousand USD | 0.0% |
| 1998 Q4 | - USD | -100.0% |
| 1998 Q2 | 100 Thousand USD | 0.0% |
| 1998 FY | 300 Thousand USD | -40.0% |
| 1998 Q3 | 100 Thousand USD | 0.0% |
| 1998 Q1 | 100 Thousand USD | 0.0% |
| 1997 Q2 | 100 Thousand USD | -50.0% |
| 1997 Q1 | 200 Thousand USD | -66.67% |
| 1997 FY | 500 Thousand USD | -82.14% |
| 1997 Q4 | 100 Thousand USD | 0.0% |
| 1997 Q3 | 100 Thousand USD | 0.0% |
| 1996 Q3 | 800 Thousand USD | 0.0% |
| 1996 Q2 | 800 Thousand USD | 33.33% |
| 1996 Q1 | 600 Thousand USD | -53.85% |
| 1996 FY | 2.8 Million USD | -40.43% |
| 1996 Q4 | 600 Thousand USD | -25.0% |
| 1995 FY | 4.7 Million USD | 2.17% |
| 1995 Q3 | 1 Million USD | -9.09% |
| 1995 Q2 | 1.1 Million USD | -8.33% |
| 1995 Q1 | 1.2 Million USD | 0.0% |
| 1995 Q4 | 1.3 Million USD | 30.0% |
| 1994 FY | 4.6 Million USD | -4.17% |
| 1994 Q4 | 1.2 Million USD | 20.0% |
| 1994 Q3 | 1 Million USD | -16.67% |
| 1994 Q2 | 1.2 Million USD | 9.09% |
| 1994 Q1 | 1.1 Million USD | -26.67% |
| 1993 Q2 | 1.4 Million USD | 180.0% |
| 1993 Q4 | 1.5 Million USD | -6.25% |
| 1993 Q1 | 500 Thousand USD | 400.0% |
| 1993 Q3 | 1.6 Million USD | 14.29% |
| 1993 FY | 4.8 Million USD | -21.31% |
| 1992 FY | 6.1 Million USD | 56.41% |
| 1992 Q4 | 100 Thousand USD | -94.12% |
| 1992 Q3 | 1.7 Million USD | -39.29% |
| 1992 Q2 | 2.8 Million USD | 75.0% |
| 1992 Q1 | 1.6 Million USD | 60.0% |
| 1991 Q3 | 1 Million USD | 100.0% |
| 1991 Q4 | 1 Million USD | 0.0% |
| 1991 Q1 | 1 Million USD | -41.18% |
| 1991 Q2 | 500 Thousand USD | -50.0% |
| 1991 FY | 3.9 Million USD | -15.22% |
| 1990 FY | 4.6 Million USD | 109.09% |
| 1990 Q3 | 1 Million USD | 0.0% |
| 1990 Q2 | 1 Million USD | 0.0% |
| 1990 Q1 | 1 Million USD | 42.86% |
| 1990 Q4 | 1.7 Million USD | 70.0% |
| 1989 FY | 2.2 Million USD | -50.0% |
| 1989 Q2 | 600 Thousand USD | 0.0% |
| 1989 Q1 | 600 Thousand USD | -45.45% |
| 1989 Q3 | 400 Thousand USD | -33.33% |
| 1989 Q4 | 700 Thousand USD | 75.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 56.3 Million USD | 98.04% |
| AngioDynamics, Inc. | 154.69 Million USD | 99.287% |
| AtriCure, Inc. | 300.37 Million USD | 99.633% |
| Avinger, Inc. | 2 Million USD | 44.911% |
| Azenta, Inc. | 263.14 Million USD | 99.581% |
| BioLife Solutions, Inc. | 46.75 Million USD | 97.64% |
| The Cooper Companies, Inc. | 2.35 Billion USD | 99.953% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | 87.846% |
| Femasys Inc. | 691.9 Thousand USD | -59.479% |
| GlucoTrack, Inc. | -13 Thousand USD | 8588.0% |
| Harvard Bioscience, Inc. | 60.86 Million USD | 98.187% |
| Hologic, Inc. | 2.22 Billion USD | 99.95% |
| ICU Medical, Inc. | 739.87 Million USD | 99.851% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 99.977% |
| KORU Medical Systems, Inc. | 16.7 Million USD | 93.396% |
| LeMaitre Vascular, Inc. | 127.04 Million USD | 99.131% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 1024.704% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 1024.704% |
| Masimo Corporation | 1 Billion USD | 99.89% |
| Microbot Medical Inc. | -106 Thousand USD | 1140.981% |
| Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | 96.666% |
| Merit Medical Systems, Inc. | 583.87 Million USD | 99.811% |
| Nephros, Inc. | 8.4 Million USD | 86.872% |
| NovoCure Limited | 381.05 Million USD | 99.71% |
| NEXGEL, Inc. | 619 Thousand USD | -78.262% |
| NEXGEL, Inc. | 619 Thousand USD | -78.262% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | 297.749% |
| OraSure Technologies, Inc. | 179.42 Million USD | 99.385% |
| Pro-Dex, Inc. | 14.55 Million USD | 92.417% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 191.42% |
| Predictive Oncology Inc. | 1.14 Million USD | 3.655% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | 80.968% |
| QuidelOrtho Corporation | 1.49 Billion USD | 99.926% |
| Repligen Corporation | 315.22 Million USD | 99.65% |
| Sanara MedTech Inc. | 57.13 Million USD | 98.069% |
| STAAR Surgical Company | 252.65 Million USD | 99.563% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 223.808% |
| Utah Medical Products, Inc. | 30.03 Million USD | 96.327% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | 99.947% |
| Jin Medical International Ltd. | 6.78 Million USD | 83.737% |